Theolytics presents CAF-targeting therapy for stromal rich tumours, and strengthens leadership team as pipeline accelerates into the clinic
/PRNewswire/ -- Theolytics, a biotechnology company harnessing viruses to combat disease, will release data on their proprietary systemic therapy for...